StockNews.com Upgrades Aehr Test Systems (NASDAQ:AEHR) to Hold

Aehr Test Systems (NASDAQ:AEHR) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Monday.

Separately, Craig Hallum upgraded Aehr Test Systems from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $12.00 to $25.00 in a research report on Wednesday, July 17th.

Aehr Test Systems Trading Down 1.1 %

Shares of Aehr Test Systems stock traded down $0.14 during trading on Monday, reaching $13.15. The company’s stock had a trading volume of 588,827 shares, compared to its average volume of 1,468,086. The stock has a 50-day moving average price of $14.10 and a two-hundred day moving average price of $13.79. The stock has a market capitalization of $380.23 million, a P/E ratio of 25.29 and a beta of 2.07. Aehr Test Systems has a one year low of $9.83 and a one year high of $53.06.

Aehr Test Systems (NASDAQ:AEHR) last issued its quarterly earnings results on Friday, July 19th. The semiconductor company reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.70. Aehr Test Systems had a net margin of 50.07% and a return on equity of 36.41%. The business had revenue of $16.60 million during the quarter. During the same period in the prior year, the business earned $0.21 EPS. As a group, sell-side analysts anticipate that Aehr Test Systems will post 0.25 EPS for the current fiscal year.

Insider Transactions at Aehr Test Systems

In related news, Director Howard T. Slayen bought 20,000 shares of the business’s stock in a transaction on Friday, August 2nd. The shares were purchased at an average price of $15.50 per share, with a total value of $310,000.00. Following the completion of the purchase, the director now owns 220,714 shares of the company’s stock, valued at approximately $3,421,067. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Howard T. Slayen bought 20,000 shares of the stock in a transaction on Friday, August 2nd. The stock was purchased at an average price of $15.50 per share, with a total value of $310,000.00. Following the completion of the purchase, the director now owns 220,714 shares of the company’s stock, valued at $3,421,067. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Fariba Danesh sold 10,000 shares of Aehr Test Systems stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $18.59, for a total transaction of $185,900.00. Following the transaction, the director now directly owns 16,390 shares in the company, valued at $304,690.10. The disclosure for this sale can be found here. 11.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD lifted its holdings in shares of Aehr Test Systems by 6.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,018 shares of the semiconductor company’s stock valued at $199,000 after purchasing an additional 961 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of Aehr Test Systems by 3.8% in the second quarter. Rhumbline Advisers now owns 39,333 shares of the semiconductor company’s stock valued at $439,000 after buying an additional 1,438 shares during the period. RiverPark Advisors LLC increased its position in shares of Aehr Test Systems by 360.8% during the first quarter. RiverPark Advisors LLC now owns 2,069 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 1,620 shares in the last quarter. Greenwood Capital Associates LLC raised its holdings in shares of Aehr Test Systems by 10.6% during the fourth quarter. Greenwood Capital Associates LLC now owns 21,046 shares of the semiconductor company’s stock worth $558,000 after acquiring an additional 2,023 shares during the period. Finally, nVerses Capital LLC bought a new stake in Aehr Test Systems in the 2nd quarter valued at $25,000. 69.69% of the stock is owned by institutional investors and hedge funds.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.